STADA Arzneimittel AG, DE0007251803

STADA Arzneimittel AG, DE0007251803

12.07.2017 - 09:10:22

STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany 2. Reason for notification X Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments   Change of breakdown of voting rights   Other reason: 3. Details of person subject to the notification obligation Name: City and country of registered office: Mr Paul E. Singer,Date of birth: 22 Aug 1944 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.Cornwall (Luxembourg) S.à r.l. 5. Date on which threshold was crossed or reached: 04 Jul 2017 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 6.71 % 1.98 % 8.69 % 62,342,440 Previous notification n/a % n/a % n/a % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in %   direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) DE0007251803 0 4,180,265 0 % 6.71 % Total 4,180,265 6.71 % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % %     Total % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % swaps 11.06.2018 Cash 1,235,000 1.98 %       Total 1,235,000 1.98 % 8. Information in relation to the person subject to the notification obligation  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more) Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Hambledon, Inc. % % % Elliott International, L.P. % % % Maidenhead LLC % % % Wolverton (Luxembourg) S.à r.l. % % % Cornwall (Luxembourg) S.à r.l. 3.72 % % %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Hambledon, Inc. % % % Elliott International, L.P. % % % Maidenhead LLC % % % Wolverton (Luxembourg) S.à r.l. % % % Cornwall (Luxembourg) S.à r.l. 3.72 % % %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Hambledon, Inc. % % % Elliott International, L.P. % % % Maidenhead LLC % % % Wolverton (Luxembourg) S.à r.l. % % % Cornwall (Luxembourg) S.à r.l. 3.72 % % %   Paul E. Singer % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliot Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership % % %   Paul E. Singer % % % Elliott International Capital Advisors, Inc. 5.75 % % 7.10 %   9. In case of proxy voting according to Sec. 22 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: 

12.07.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English

Company: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel

Germany Internet: www.stada.de   End of News DGAP News Service

591635  12.07.2017 

@ dgap.de

Amazon wird sich schwarzärgern, aber …

… wir schenken Ihnen den Report „Börsenpsychologie - Markttechnik für Trader“ heute trotzdem kostenfrei. Normalerweise kostet der Report im Onlinehandel 39,99 Euro.

Sie können sich den genialen Report heute jedoch absolut kostenfrei sichern. Wir senden Ihnen den Report vollkommen KOSTENFREI zu.

Jetzt HIER klicken und dank richtigen Timing reich an der Börse werden!